Passiflora incarnata L. · herb
Evidence tier: weak
Calms an overactive mind and reduces anxiety related sleep disruption
Thought to act on GABA, the brain's main calming signal, in a way loosely comparable to how sedative drugs work but far weaker and without full receptor activation. That is the standard explanation and it is a laboratory hypothesis, not a demonstrated mechanism in people. It is worth being precise about what is NOT established: the specific story that the flavonoid chrysin binds the benzodiazepine site of the GABA A receptor is a mechanistic proposal drawn from in vitro and animal work, and chrysin is not even the flavonoid Passiflora incarnata is chiefly standardised to. Treat the mechanism as plausible, unproven, and not a licence to imply benzodiazepine like effects.
Weak, and the regulatory endorsement the seed leans on does not exist as described. The EMA HMPC registers Passiflora incarnata herba as a TRADITIONAL herbal medicinal product, NOT a well established use one, for relief of mild symptoms of mental stress and to aid sleep, in adults and adolescents over 12. That status is granted on long standing use of at least 30 years, explicitly BECAUSE the clinical trial evidence was judged insufficient; the EMA assessment records that the available trials had serious shortcomings preventing firm conclusions. That is the ceiling. The trial base underneath is thin and mismatched to the consumer use. The most complete synthesis, a 2020 systematic review of Passiflora incarnata in neuropsychiatric disorders (PMID 33352740), found only 9 clinical trials, lasting from ONE DAY to 30 days. Eight of the nine studied HEALTHY subjects, and most of them measured situational anxiety before a medical procedure such as spinal anaesthesia, dental work or surgery, which is not the same thing as everyday anxiety or chronic stress. Exactly ONE trial studied people with diagnosed generalised anxiety disorder: Akhondzadeh 2001, n=36, which reported passionflower extract non inferior to oxazepam over 4 weeks. One small non inferiority trial against a benzodiazepine, never replicated, is not a foundation. The sleep evidence is one small crossover trial of passionflower tea (Ngan and Conduit 2011, n=41) reporting improved SUBJECTIVE sleep quality. So: a real traditional registration, a plausible mechanism, and a handful of small short trials that do not establish efficacy for the use people buy it for.
EMA traditional use: 1 to 8 g of the dried herb daily, in divided doses, as a herbal tea or equivalent preparation. Adults and adolescents over 12 only. The EMA instructs that a doctor or qualified healthcare practitioner be consulted if symptoms last more than 2 weeks or worsen during use, which effectively caps self treatment at a fortnight.
For sleep: take 30 to 60 minutes before bed. For anxiety: 3× daily dosing used in clinical trials. Onset: 30 to 60 minutes.
Onset: ~7 days
Well tolerated in short term use. May potentiate sedatives and benzodiazepines, additive CNS depression. Avoid combining with MAOIs, potential serotonin interaction via harman alkaloids. Not for use in pregnancy, uterotonic activity documented. Mild drowsiness is a common side effect, do not drive.
Pregnancy: avoid
Breastfeeding: caution
Used by Native American peoples for anxiety and as a sedative. Adopted by European herbalists in the 16th century for nervous conditions and insomnia. Still one of the most widely recommended herbs in Western herbal medicine for sleep onset. The lemon balm and passionflower combination has been specifically studied for sleep quality.
Active compounds: flavonoids (vitexin, isovitexin, orientin), maltol
Remedies using Passionflower · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.